These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28931501)

  • 1. Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
    Katapodi MC; Viassolo V; Caiata-Zufferey M; Nikolaidis C; Bührer-Landolt R; Buerki N; Graffeo R; Horváth HC; Kurzeder C; Rabaglio M; Scharfe M; Urech C; Erlanger TE; Probst-Hensch N; Heinimann K; Heinzelmann-Schwarz V; Pagani O; Chappuis PO
    JMIR Res Protoc; 2017 Sep; 6(9):e184. PubMed ID: 28931501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study.
    Kim S; Aceti M; Baroutsou V; Bürki N; Caiata-Zufferey M; Cattaneo M; Chappuis PO; Ciorba FM; Graffeo-Galbiati R; Heinzelmann-Schwarz V; Jeong J; Jung MM; Kim SW; Kim J; Lim MC; Ming C; Monnerat C; Park HS; Park SH; Pedrazzani CA; Rabaglio M; Ryu JM; Saccilotto R; Wieser S; Zürrer-Härdi U; Katapodi MC
    JMIR Res Protoc; 2021 Jun; 10(6):e26264. PubMed ID: 34114954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
    Nikolaidis C; Ming C; Pedrazzani C; van der Horst T; Kaiser-Grolimund A; Ademi Z; Bührer-Landolt R; Bürki N; Caiata-Zufferey M; Champion V; Chappuis PO; Kohler C; Erlanger TE; Graffeo R; Hampel H; Heinimann K; Heinzelmann-Schwarz V; Kurzeder C; Monnerat C; Northouse LL; Pagani O; Probst-Hensch N; Rabaglio M; Schoenau E; Sijbrands EJG; Taborelli M; Urech C; Viassolo V; Wieser S; Katapodi MC;
    Public Health Genomics; 2018; 21(3-4):121-132. PubMed ID: 30695780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort.
    Sarki M; Ming C; Aissaoui S; Bürki N; Caiata-Zufferey M; Erlanger TE; Graffeo-Galbiati R; Heinimann K; Heinzelmann-Schwarz V; Monnerat C; Probst-Hensch N; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; On Behalf Of The Cascade Consortium
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring family communication preferences in hereditary breast and ovarian cancer and Lynch syndrome: a national Canadian survey.
    Burke K; Dawson L; Hodgkinson K; Wilson BJ; Etchegary H
    J Community Genet; 2024 Jul; ():. PubMed ID: 39046652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
    Baroutsou V; Underhill-Blazey ML; Appenzeller-Herzog C; Katapodi MC
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort.
    Sarki M; Ming C; Aceti M; Fink G; Aissaoui S; Bürki N; Graffeo R; Heinimann K; Caiata Zufferey M; Monnerat C; Rabaglio M; Zürrer-Härdi U; Chappuis PO; Katapodi MC; The Cascade Consortium
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
    Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
    Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
    Modell SM; Greendale K; Citrin T; Kardia SL
    Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.
    Katapodi MC; Jung M; Schafenacker AM; Milliron KJ; Mendelsohn-Victor KE; Merajver SD; Northouse LL
    JMIR Cancer; 2018 Apr; 4(1):e7. PubMed ID: 29653920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
    Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S;
    Fam Cancer; 2024 Jun; 23(2):121-132. PubMed ID: 38662264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low rates of cascade genetic testing among families with hereditary gynecologic cancer: An opportunity to improve cancer prevention.
    Griffin NE; Buchanan TR; Smith SH; Leon AA; Meyer MF; Liu J; Tabak RG; Fuh KC; Thaker PH; Powell MA; Mutch DG; Massad LS; Colditz GA; Hagemann AR
    Gynecol Oncol; 2020 Jan; 156(1):140-146. PubMed ID: 31780235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Privacy and utility of genetic testing in families with hereditary cancer syndromes living in three countries: the international cascade genetic screening experience.
    Barnoy S; Dagan E; Kim S; Caiata-Zufferey M; Katapodi MC; ;
    Front Genet; 2023; 14():1109431. PubMed ID: 37229185
    [No Abstract]   [Full Text] [Related]  

  • 16. BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.
    Aeilts AM; Carpenter KM; Hovick SR; Byrne L; Shoben AB; Senter L
    J Genet Couns; 2023 Apr; 32(2):475-485. PubMed ID: 36426678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling.
    Garcia C; Sullivan MW; Lothamer H; Harrison KM; Chatfield L; Thomas MH; Modesitt SC
    J Obstet Gynaecol Res; 2020 Sep; 46(9):1835-1841. PubMed ID: 32656916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
    Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
    Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Openness of Communication in Families With Hereditary Breast and Ovarian Cancer Syndrome: Natural Language Processing Analysis.
    Baroutsou V; Cerqueira Gonzalez Pena R; Schweighoffer R; Caiata-Zufferey M; Kim S; Hesse-Biber S; Ciorba FM; Lauer G; Katapodi M;
    JMIR Form Res; 2023 Jan; 7():e38399. PubMed ID: 36656633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.